Archives

MHD has four upcoming sector specific Novel Influenza A (H1N1) summits.

1. Milwaukee Mayoral Business Summit — September 15, 2009
2. (2) K-12 and Childcare Summits — September 15–16, 2009
3. Healthcare Summit — September 18, 2009
4. Faith Based Organizations and Community Based Organizations — September 25, 2009

Situational Reports from the City of Milwaukee Health Department

1. December 17, 2009
2. December 10, 2009
3. December 3, 2009
4. November 25, 2009
5. November 19, 2009
6. November 12, 2009
7. November 5, 2009
8. October 29, 2009
9. October 22, 2009
10. October 15, 2009
11. October 8, 2009
12. October 1, 2009
13. September 24, 2009
14. September 17, 2009
15. September 10, 2009

City of Milwaukee Health Department vaccination clinic advisory, 11/19/09

CITY OF MILWAUKEE Health Department ANNOUNCES PLANS FOR ADDITIONAL PUBLIC H1N1 VACCINATION CLINICS

City receives shipment of 5,000 doses of both injectable and intranasal vaccine

MILWAUKEE (November 3, 2009) – The City of Milwaukee Health Department (MHD) today has received additional doses of both the injectable and intranasal H1N1 vaccine, and will hold two vaccination clinics this week: Thursday, November 5, 2009 from 2:00 pm to 7:00 pm at Sarah Scott Middle School, located at 1017 N. 12th Street; and Friday, November 6, 2009 from 4:00 pm to 9:00 pm at South Division High School, 1515 W. Lapham Blvd.

This afternoon, the MHD received approximately 3500 doses of H1N1 injectable vaccine and 1500 doses of the intranasal vaccine, which will be added to the approximately 650 doses of intranasal vaccine remaining from previous clinics. Vaccine will be administered in accordance with the recommendations released by the State Division of Public Health:

• Pregnant women
• Children ages 6 months-18 years
• Healthcare workers with direct patient contact
• Caregivers and household contacts of infants under 6 months of age

A clinic consent form is posted on the MHD website and is available in both English and Spanish. The MHD strongly encourages residents to download and complete the form and bring it with them to the clinic to assist in quicker registration processing. Persons outside the City of Milwaukee may call 211 for information on H1N1 vaccination clinic dates, times and locations within their community.

City of Milwaukee Health Department to hold H1N1 clinic on Friday, October 30, 2009

Below is a memo from the City of Milwaukee Health Department

Given the release of Department of Public Health guidance strongly urging healthcare providers to restrict H1N1 vaccine to a subset of previously identified target groups, the City of Milwaukee Health Department will hold a large public clinic for select eligible persons this Friday, Oct 30th. The clinic will be held at Sara Scott Middle School from 2-7PM. Sara Scott Middle School is located at 1017 N 12th St. Only, Intranasal H1N1 is available for this clinic. Given the limited supply, the target population for this public clinic will be:

• healthy children 2-4 years of age
• healthy household contacts and caregivers (that do not have underlying health conditions) to infants <6 mos and are ages 5-49 years
• healthcare workers ages 2-49 yrs without underlying health conditions

Please refer those that fit these categories to this clinic.

MHD TO HOLD FIRST H1N1 VACCINATION CLINIC ON FRIDAY, 10/23 AND SATURDAY, 10/24

Please see the attached Media Advisory regarding the City of Milwaukee Health Department holding the first public Mass H1N1 Vaccine Clinic this Friday, October 23rd and if enough vaccine remains there will be a clinic on Saturday, October 24th.

Please note that the groups being initially targeted for H1N1 vaccination due to risk for severe disease or complications of H1N1 flu illness include:

• Anyone aged 6 months to 24 years
• Pregnant women
• People aged 25-64 who have chronic medical problems like asthma, diabetes, heart disease, or immune system problems
• People who live with or care for infants under 6 months of age
• Healthcare workers and Emergency Medical Services personnel
  
  

This vaccine is being proved free of charge to the public.